𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Different Expressed Locations of Cancer Stem Cell Markers CD133 and CD44 in Well Differentiated Gastric Cancer and Adenoma

✍ Scribed by Shibata, Tomoyuki ;Kamatani, Akemi ;Nakamura, Masakatsu ;Tahara, Tomomitsu ;Hirata, Ichiro

Book ID
122236768
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
41 KB
Volume
140
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CD133 and CD44 Cell surface markers do n
CD133 and CD44 Cell surface markers do not identify cancer stem cells in primary human gastric tumors
✍ Alba Rocco; Eleonora Liguori; Giuseppe Pirozzi; Virginia Tirino; Debora Compare; πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 403 KB

## Abstract Emerging evidence suggests that tumors contain and are driven by a cellular component that displays stem cell properties, the so‐called cancer stem cells (CSCs). CSCs have been identified in several solid human cancers; however, there are no data about CSCs in primary human gastric canc

CD133 and CD44 are universally overexpre
CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers
✍ Junwei Chen; Tianhua Guo; Lei Zhang; Li-Xuan Qin; Samuel Singer; Robert G. Maki; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 495 KB

## Abstract Although imatinib mesylate has been a major breakthrough in the treatment of advanced gastrointestinal stromal tumors (GIST), complete responses are rare and most patients eventually develop resistance to the drug. Thus, the possibility of an imatinib‐insensitive cell subpopulation with